David Saito-Chung

Wrote on 30-plus sports plus #stocks & #economics at Kyodo News in #Japan • , 1994-99. Now #IBDLive cohost, deputy markets editor at IBD @IBD_DChung

[David Saito-Chung @SatioChung]

In The Market II: With 20 minutes left Tue, #NYSE volume looks higher as $SPX shows a solid gain w other indexes. #marketsurge homepage counts 7 #breakouts among #stocks -- might be the highest in weeks if not months #IBDinvestors #IBD_ECarson #IBD_DChung

[David Saito-Chung @SatioChung]

In The Market: $WT joined IBD Leaderboard April 20; we lacked #patience as it tested the 50-day MA. Perhaps a better #trading #strategy is this covered call idea from our #options columnist #OptiontradinIQ https://t.co/epCOYL22qk… #dividends #investingtips101 #IBDinvestors

[David Saito-Chung @SatioChung]

In The Market: $ANET breaks out again. It's been holding up as a #tech rep among top #growth #stocks in IBD's Long-Term Leaders. More here https://t.co/l9fTV6CcW0… #IBD_ECarson #IBD_DChung #IBDinvestors #AI #datacenter #leaders #innovation $CSCO $QQQ https://t.co/0GAVDOypCF

[David Saito-Chung @SatioChung]

Market III: Let's keep eyes on #energy #stocks $XLE down 4 straight days, sinks below a 1st low of 53.41. Potential double bottom? A test of the 200-day MA first? Daily chart on #marketsurge #IBDinvestors #IBD_DChung #IBD_ECarson #AlissaCoram #ETF #trading #charts $OIH $XOP

[David Saito-Chung @SatioChung]

In The Market II: Did your #bank #stocks rally today? $KBE up 1.7% in big vol, floats past the 5% IBD buy zone from a 65.44 entry. 20-week base began Feb. 9. 85 Relative Strength Rating #IBDinvestors #marketsurge #IBD_ECarson #IBD_DChung $KRE $PNC $XLF $ZION #investing

[David Saito-Chung @SatioChung]

In The Market IV: Front page piece in @WSJ weekend edition. On Tue, $EWY falls 12% #AI #chips #stocks #bubble #boom #investing #psychology #Korea #Asia $EWT $SMH $SOXX #IBD_ECarson #IBD_DChung #IBDInvestors

[David Saito-Chung @SatioChung]

On Saturday: I'm truly excited to cohost a 4-hr a primary-level #webinar w senior product coach Harold Morris of @marketsurge to help new investors gain an edge in #stocks We'll cover buy/sell rules, #psychology of #charts and #timing the mkt. More here https://t.co/uigjkxAo54

[David Saito-Chung @SatioChung]

Market III: $RY has joined IBD's Big Cap 20, more evidence of #money flowing into money center #banks The stock cleared a nine-week base at 176.19 on April 17, 9 days after the S&P 500's follow-through on April 8 #IBDinvestors #RBC #investing #charts
https://t.co/vBDwdmQhQR

[David Saito-Chung @SatioChung]

Thanks Marty. Another good lesson in not to catch a falling knife in #biotech #pharma #genetics #genome #dna #healthcare #medicine #stocks #risks #downtrend #WhenToSell

[Marty Chargin @MartyChargin]

$LLY ... Eli Lilly: Sangamo Therapeutics enters into asset sales agreement with Eli Lilly and Astellas Pharma as Sangamo commences voluntary Chapter 11 proceedings(1,103.68)
Sangamo Therapeutics, Inc. (SGMO) announces that it has entered into two separate asset sale agreements, one with Eli Lilly and Company (LLY) for Sangamo's capsid delivery platform, zinc finger platform, modular integrase platform and the prion disease program, ST-506, and another with Astellas Pharma Inc. for the Fabry disease program, isaralgagene civaparvovec, or ST-920.
Concurrent with the execution of these asset sale agreements, Sangamo has commenced voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware to facilitate a court-supervised reorganization, which is expected to include the auction of substantially all of Sangamo assets.
To anchor the sale process, Lilly and Astellas will each serve as "stalking horse bidders" for the sale of the assets contemplated by their respective agreements. A stalking horse asset sale agreement establishes a strong baseline offer and is intended to help maximize value for all stakeholders through the Chapter 11 auction process.
Certain other company assets, including the clinical-stage ST-503 program to treat chronic neuropathic pain, the giroctocogene fitelparvovec program to treat hemophilia A, and Sangamo's cell therapy and regulatory T cell (Treg) assets, are not included in either stalking horse bid, and are also expected to remain available to interested bidders at the auction.
"Following a comprehensive review of available alternatives, we believe this process provides a clear framework to pursue value-maximizing transactions," said Sandy Macrae, Chief Executive Officer of Sangamo Therapeutics. "Our priority is to execute a disciplined and efficient sale process while supporting all of our stakeholders. We are also pleased to have signed agreements with two large pharmaceutical companies to serve as stalking horse bidders in the process, underscoring the strategic interest in our assets."

[David Saito-Chung @SatioChung]

Market II: As #stocks fell Tue, investors bought back long-dated US Treasuries. All-important 10-year bond yield now at 4.49%. Up 21 basis points for the qtr, up 33 bp for the year. The rise in cost of money remains intact #Cboe #IBD_ECarson #marketsurge #investing #stocks

[David Saito-Chung @SatioChung]

In The Market: Some folks ignore the Dow industrials. Yet blue chips sometimes shine amid a big drop by $QQQ as #insurance #financial #stocks showed relative strength today. $TRV cleared a mild double bottom base at 309.88. Not a screamer. But it's clearing resistance near 313

[David Saito-Chung @SatioChung]

#investing #trading #webinar #news #knowledge #biotech #growth #value #stocks #biopharma #genetics #cancer #psychedelics #research #future #aaiilainvestors #AAIISentiment #IBDinvestors #AGatlin_IBD

[David Saito-Chung @SatioChung]

In #Bonds Today: With a new #federalreserve chair sworn in, what do traders in #fedfunds #futures think about the future cost of #money? #CMEGroup FedWatch sees a small yet notable 19% probability of a quarter-point hike at the July 29 mtg https://t.co/7eD5sGrX8p… #IBD_ECarson

[David Saito-Chung @SatioChung]

In The Market: Are #EU #stocks back? #DowJones notes STOXX Europe 600 rose 3% this week to 625.12. It's now up 5.6% YTD. On #IBDLive today w #IBD_JNielsen #AlissaCoram and the inimitable Steve Swetz, we noted the big run by $NOK lately. Who's next? $ERIC $EWG $EWP #IBD_DChung

[David Saito-Chung @SatioChung]

Last week senior stock market strategist, friend Mike Webster and I viewed Jeff Koons’ brilliant “Split Rocker” #plant #sculpture next to #IBDInvestors #office See the watering pipes hidden inside? Like #charts of #stocks it pays to look twice or thrice #mwebster1971 #lacma

[David Saito-Chung @SatioChung]

Two weekends ago we drove around one of the hardest hit neighborhoods by the Jan 2025 Eaton #fire This #Altadena area had new #homes popping up including an #ADU manufactured in #China We might see more imported #houses going forward #SoCal #LA #construction #economy #trade

[David Saito-Chung @SatioChung]

Thousands of #flowers and luckily no #pollen attack for either of us! Cheers Webby it was a short but FUN walk to Jeff Koons' Split Rocker living sculpture! #LA #art #LACMA #JeffKoons

[Mike Webster @mwebster1971]

Spent the day at IBD’s LA office, my good buddy Hatman Dave was nice enough to show some cool sights nearby
@IBD_DChung @SaitoChung @IBDinvestors

[David Saito-Chung @SatioChung]

In The Market: On today's #IBDLive special guest #dryan310 commented on #biotech #ETF $XBI. Indeed, some of the sector's top small and midcap #leaders #IBD50 https://t.co/asgXvplelJ… $ANAB $AXSM $TGTX $INDV #AGatlin_IBD #IBD_DChung #IBDinvestors https://t.co/nOmTW48izE

[David Saito-Chung @SatioChung]

In The Market: #IBDLive attendees know #IBD_CGessel is our Go-To for #bullish views on REITs (haha!) Seriously, this #REIT has done very https://t.co/asgXvplelJ… #IBD50 #IBD_DChung #IBD_ECarson #AlissaCoram $WELL #dividends #investing #retirement https://t.co/k8s0TNpQN5

[David Saito-Chung @SatioChung]

Hi friends, I'll fill in for Ken Shreve and joining #AlissaCoram for today's Stock Market Today #video after the market close. We'll discuss 3 #stockstowatch including $TER $CAT $GOOGL Pls join here https://t.co/pcxiUqWXMr… #IBDinvestors #IBD_Alexis #trading #investing $QQQ